|Previous Section||Index||Home Page|
Mr. Byrne: The recommendations in the Forget Me Not" report were principally addressed to local health and social care agencies. It is for these local agencies to decide on their priorities in the light of local circumstances.
Mr. Byrne: It is for local authorities and health service providers to determine how best to provide services to meet the needs of individuals with autism, including those with autistic spectrum disorder.
David T.C. Davies: To ask the Secretary of State for Health pursuant to the answer of 14 June 2005, Official Report, column 302W on the British Pregnancy Advisory Service; when she expects to complete her consideration of the Chief Medical Officer's report on the BPAS. 
Mr. Neil Turner: To ask the Secretary of State for Health what research her Department has undertaken into the effect of benzen particulates and gases emanating from the fire at Broomfield Tip, Standish, on the health of residents in the vicinity. 
Norman Baker: To ask the Secretary of State for Health what quantities of Bt 10 maize have been imported into the UK; over what period; and what quantities she estimates have been consumed by (a) animals and (b) humans. 
The exact quantity of Bt 10 maize imported into the United Kingdom is not known. It is estimated that up to 0.025 per cent., of the 200104 United States of America maize harvests may have contained Bt 10 maize and imports into the EU during this period may have contained Bt 10 maize at this level. The European food industry has stated to the commission that it only uses US maize products that are from protected non-genetically modified sources. The quantities of Bt 10 maize imported to the UK for food use should therefore be nil. Maize in the form of corn
28 Jun 2005 : Column 1500W
gluten feed and brewers' grains is imported from the US for animal feed. However, the amount of Bt 10 maize potentially consumed by animals is not known.
Mr. Crabb: To ask the Secretary of State for Health what the mean waiting time in days from the time of diagnosis by consultant to hospital admission for treatment was for (a) cancer of the brain, (b) cancer of the prostate, (c) cancer of the ovary and (d) cancer of the liver in (i) 199798 and (ii) 200304. 
Helen Jones: To ask the Secretary of State for Health which NHS trusts have contracts with private companies for the examination of cervical cancer smear tests; which companies are involved; and whether any send smear tests outside the UK for screening. 
Ms Rosie Winterton: We do not centrally collect data on the use of independent sector providers of cervical screening services, and we are not aware that any cervical screening slides are sent outside of the United Kingdom to be interpreted. Primary care trusts (PCTs) are responsible for commissioning cervical screening services for their local populations to explicit national quality standards. It is a matter for individual PCTs to decide on who provides their local service, whether in the national health service or the independent sector.
Ms Rosie Winterton: There are several monoclonal antibodies that are licensed for the treatment of cancer and can be prescribed to patients on the national health service. These are cetuximab for the treatment of advanced colorectal cancer; trastuzumab for the treatment of advanced breast cancer, alemtuzumab for the treatment of chronic lymphocytic leukaemia and rituximab for the treatment of follicular non-Hodgkin's lymphoma.
The National Institute for Clinical Excellence (NICE) has appraised two of these drugstrastuzumab for advanced breast cancer and rituximab for the treatment
28 Jun 2005 : Column 1501W
of follicular non-Hodgkin's lymphoma. These appraisals included an evaluation of the available research evidence. NICE is now in the process of appraising cetuximab for advanced colorectal cancer. This guidance is expected to be published in November 2006.
Mr. Byrne: The Office of Fair Trading published a report on care homes for older people on 18 May 2005. The report made a number of recommendations to the Government, which are currently under consideration.
Tom Levitt: To ask the Secretary of State for Health what contribution to the cost of care provision came from (a) equity release and (b) other property based loans in (i) absolute and (ii) percentage terms, in the last period for which figures are available; and what plans she has to bring forward proposals to change this proportion. 
We made a manifesto commitment to provide the right framework to make staying at home an attractive option for people in need of long-term care for schemes, through schemes such as equity release. We are considering how to take forward this commitment.
|Next Section||Index||Home Page|